Olaf Prien

457 citations
16 papers · 353 indexed · h-index 10
Topics
Prostate Cancer Treatment and Research (6 papers)Chemical Synthesis and Analysis (3 papers)Radiopharmaceutical Chemistry and Applications (3 papers)

In The Last Decade

Olaf Prien

16 papers receiving 337 citations

Peers

Olaf Prien
Comparison fields: 5 of 53
  • Pulmonary and Respiratory Medicine 141
  • Organic Chemistry 126
  • Molecular Biology 98
  • Radiology, Nuclear Medicine and Imaging 68
  • Oncology 56
Replace Ana Krivokuća with:
Ana Krivokuća Serbia
Arwed Cleve Germany
Gary Wilkinson United Kingdom
S. Seeber Germany
A. Thomas DiCioccio United States
Benjamin P. Haynes United Kingdom
Aakanksha Khandelwal United States
C. Gaggini Italy
Hitisha Patel United States
Douglas W. Beight United States
Olaf Prien relative to Ana Krivokuća Serbia Ana Krivokuća's profile →
Citations per field
00.5×5.2×
Ana Krivokuća · 1×
Citations per year

Countries citing papers authored by Olaf Prien

Since Specialization
Citations

This map shows the geographic impact of Olaf Prien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Prien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Prien more than expected).

Fields of papers citing papers by Olaf Prien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olaf Prien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Prien. The network helps show where Olaf Prien may publish in the future.

Co-authorship network of co-authors of Olaf Prien

This figure shows the co-authorship network connecting the top 25 collaborators of Olaf Prien. A scholar is included among the top collaborators of Olaf Prien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olaf Prien. Olaf Prien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 9
2 11
3 9
4 71
5 66
6 3
7 9
8 25
9 25
10 5
11 30
12 71
13 11
14 1
15 1
16 6

About Olaf Prien

Olaf Prien is a scholar working on Organic Chemistry, Pulmonary and Respiratory Medicine and Pharmacology, having authored 16 papers that have together received 353 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (6 papers), Chemical Synthesis and Analysis (3 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). The work is most often cited by research in Organic Chemistry (126 citations), Pulmonary and Respiratory Medicine (141 citations) and Pharmacology (31 citations). Olaf Prien has collaborated with scholars based in Germany, Finland and United Kingdom. Frequent co-authors include Christian Zurth, Mikko Koskinen, Robert E. Fricke, Hille Gieschen, Timo Korjamo, Karsten Denner, Martina Schäfer, Gary Wilkinson, Gerhard Siemeister and Hans Briem. Their work appears in journals such as Journal of Clinical Oncology, Journal of Medicinal Chemistry and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026